Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
Efforts to Rein In AI Tap Lesson From Social Media: Don't Wait Until It's Too Late
Business

Efforts to Rein In AI Tap Lesson From Social Media: Don't Wait Until It's Too Late

Activists and officials race to shape rules and public understanding of new artificial intelligence tools. Source link

The Big Question for Managers on AI: Who Gets the Job of Figuring It Out?
Business

The Big Question for Managers on AI: Who Gets the Job of Figuring It Out?

Companies create committees and teams to seize on the potential of artificial intelligence as executives debate how best to handle the technology. Source link

ChatGPT Under Investigation by FTC
Business

ChatGPT Under Investigation by FTC

The agency is investigating whether OpenAI’s chatbot has harmed individuals by publishing false information about them. Source link

Want to See Your Future Babies? This Viral App Can Show You.
Business

Want to See Your Future Babies? This Viral App Can Show You.

The photo-editing platform Remini is triggering baby fever with realistic childhood images. But there are drawbacks. Source link

Google's Bard AI Chatbot Adds More Languages to Take On ChatGPT
Business

Google's Bard AI Chatbot Adds More Languages to Take On ChatGPT

The latest version will also include a privacy hub for all users. Source link

ChatGPT Already Floods Some Corners of Internet With Spam
Business

ChatGPT Already Floods Some Corners of Internet With Spam

Online publishers have been inundated with junk-article pitches as websites using AI-generated content multiply. Source link

KPMG Plans $2 Billion Investment in AI, Cloud Services
Business

KPMG Plans $2 Billion Investment in AI, Cloud Services

An expanded partnership with Microsoft is expected to bring in $12 billion in revenue for KPMG over five years, the Big Four accounting firm said.

FDA Approval Isn't Always a Happy Day for Biotech Investors
Business

FDA's OK Isn't Always a Happy Day for Biotech Investors

In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link

FDA Approval Isn't Always a Happy Day for Biotech Investors
Finances

FDA Approval Isn't Always a Happy Day for Biotech Investors

In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link